📰 Contract Development News
Page 40 - Contract Development News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Contract Development. Real-time updates on events, politics, business and more.
March 30, 2023
/PRNewswire/ -- Piramal Pharma Solutions, a patient-centric Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd (PPL),...
March 30, 2023
BERLIN, Germany, March 30, 2023 / B3C newswire / -- ProBioGen, the Berlin-based CDMO and technology provider, reported today that revenues for the fiscal year 2022 (FY22) grew 35% vs FY21.In a year marked by new geopolitical and macroeconomic challenges, ProBioGen was able to carry on its rapid growth trajector...
March 29, 2023
According to a new Growth Plus Reports research, the global prescription drugs market is expected to reach US$ 2067.25 billion by 2030, with a revenue
March 28, 2023
CDMO honored as winner in all six core award categories Vetter celebrates its second consecutive year earning this award in six categories with three additional honors in the CDMO Leadership Awards
March 27, 2023
Hovione and Laxxon Medical Establish an Agreement for the cGMP Production of 3D Screen Printed Pharmaceutical Applications New York, 03/27/2023 / 08:00, EST/EDT - EQS Newswire - Laxxon Medical This partnership will create an opportunity for the pharmaceutical industry to develop and manufacture ...
March 27, 2023
Investegate announcements from Laxxon Medical, Hovione and Laxxon Medical Establish an Agreement for the cGMP Production of 3D Screen Printed Pharmaceutical Applications
March 27, 2023
/PRNewswire/ -- The "Bioprocess Validation Market Size, Share & Trends Analysis Report, By Testing Type, By Stage, By Mode, By Region, and Segment Forecasts,...
March 26, 2023
Benchmark restated their buy rating on shares of Orgenesis (NASDAQ:ORGS – Get Rating) in a research note issued to investors on Wednesday morning, Benzinga reports. Benchmark currently has a $6.00 target price on the stock. Orgenesis Price Performance Orgenesis stock opened at $1.42 on Wednesday. The firm has a 50-day moving average price of $1.89 […]
March 24, 2023
The global prostate cancer radiotherapy market is projected to register a revenue CAGR of 5.30% between 2023 to 2031, according to the latest evaluation
March 21, 2023
/PRNewswire/ -- According to a new report published by UnivDatos Markets Insights, the Advanced Therapy Medicinal Products CDMO Market was valued at more than...